Argentina vs Turkmenistan: Number of deaths from cardiovascular diseases by type
Argentina
126.51 deaths
in 2021
Turkmenistan
129.45 deaths
in 2021
Argentina rank
90th
Turkmenistan rank
89th
Number of deaths from cardiovascular diseases by type over time
- Argentina
- Turkmenistan
How they compare
Turkmenistan currently reports 129.45 deaths against 126.51 deaths in Argentina, a difference of 2.94 deaths.
The two have swapped places 3 times across 22 shared years of data; in 2000 it was Argentina ahead.
Argentina ranks 90th and Turkmenistan ranks 89th of 194 countries.
Across the 3 decades both report, Argentina averaged higher in 2 and Turkmenistan in 1.
Head to head by decade
| Decade | Argentina | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 221.66 deaths | 160.05 deaths | 61.61 deaths | Argentina |
| 2010s | 166.13 deaths | 117.71 deaths | 48.43 deaths | Argentina |
| 2020s | 119.05 deaths | 126.78 deaths | 7.73 deaths | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of deaths from cardiovascular diseases by type, Argentina or Turkmenistan?
- Turkmenistan, at 129.45 deaths against 126.51 deaths in Argentina as of 2021.
- What is the difference in number of deaths from cardiovascular diseases by type between Argentina and Turkmenistan?
- 2.94 deaths, with Turkmenistan ahead.
- How many years of comparable data are there for Argentina and Turkmenistan?
- 22 years are reported by both, from 2000 to 2021.
- How do Argentina and Turkmenistan rank globally for number of deaths from cardiovascular diseases by type?
- Argentina ranks 90th and Turkmenistan ranks 89th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Number of deaths from cardiovascular diseases by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from rheumatic heart disease in both sexes.